The Era of Ozempic (and GLP-1s): Considerations and Perspective from Eating Disorder Healthcare Professionals
As the national volume of new GLP1-RA medications, such as Ozempic, continues to grow louder, so has our attention to these drugs’ potential to negatively impact eating disorder prevalence and symptomatology. These medications work to increase satiety and decrease appetite with the intention of weight loss through caloric restriction. Dietary restriction can be a significant precipitating factor in the development of an eating disorder. And, for those who already exhibit disordered eating, ongoing dietary restriction keeps those individuals locked in a cycle of restrict, binge, and purge. A...Read moredditionally, once use of these medications is discontinued, individuals find themselves struggling with rebound weight gain and increased potential for metabolic malfunctions. Those with an underlying eating disorder or a predisposition for the development of an eating disorder, may turn to eating disorder behaviors to counteract their increase in body weight. Healthcare professionals are in a unique position to identify misuse of these drugs and mitigate the development or perpetuation of an eating disorder.
This presentation, led by a licensed clinical social worker and registered dietitian, is intended to educate therapists, dietitians, healthcare professionals, and fitness professionals about these medications, their use, and misuse. We will also focus on how to identify the misuse of these medications in our client population as well as identify therapeutic and nutritional interventions to help support our client’s eating disorder recovery without the misuse of GLP1-RA medications. Less...
Learning Objectives
- List the different GLP1-RA medications on the market, how they work, and why they are prescribed.
- List the steps and describe the process of assessment for the misuse of GLP-1 medications by clients struggling with eating disorders and disordered eating.
- Develop two therapeutic and/or nutritional interventions to support patient’s recovery from an eating disorder related to or exacerbated by the misuse of GLP1-RA medications.
Target Audience
Learning Levels
- Intermediate
Thursday, February 27, 2025
425 E Main St, Carmel, IN, 46032
10:00 AM EST - 12:00 PM EST
Agenda
10:00am - 10:30am: Welcome, Coffee & Nourishment
10:30am - 12:00pm: Presentation and Questions
CE Information - Earn 1.5 CE Credit Hours
CE Approvals
New York State Education Department's State Board for Social Work
New York Education Department for Licensed Mental Health Counselors
New York State Education Department's State Board for Psychology
New York State Education Department's State Board for Marriage and Family Therapy

Joint Accreditation
Commission on Dietetic Registration
Interprofessional Continuing Education
American Psychological Association
CE Process Info
Before the event, you will receive an email from CE-Go with access to the virtual event. After the event, you will receive access to your evaluation and continuing education certificate via a personalized "attendee dashboard" link, hosted on the CE-Go website. This link and access to the virtual event will be sent to the email account you used to register for the event.
Upon accessing the CE-Go "attendee dashboard", you will be able to:
- Complete evaluation forms for the event
- Download your continuing education certificate in a PDF format
If you have any questions or concerns regarding the CE-Go platform, please contact CE-Go at 888-498-5578 or by email at support@ce-go.com Please Note: Emails for this event will come from "support@ce-go.com".
If you have any continuing education related questions, please contact your event organizer.
Please make sure to check your spam/junk folder in case those emails get "stuck". We'd also suggest "Allowlisting" support@ce-go.com. This tells your email client that you know this sender and trust them, which will keep emails from this contact at the top of your inbox and out of the junk folder.
Disclosure
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPSCE Learning Systems adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CE activity ― including faculty, planners, reviewers, or others ― are required to disclose all relevant financial relationships with ineligible entities (formerly known as commercial interests).
The following relevant financial relationships have been disclosed by this activity’s planners, faculty, and the reviewer:
PLANNERS AND REVIEWER
The planners of this activity have reported that they have no relevant financial relationships.
FACULTY
The faculty of this activity have reported that they have no relevant financial relationships.